Patents by Inventor Meir Preis

Meir Preis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for determining response to neoadjuvant therapy and survival using MicroRNA-10b
    Patent number: 8580513
    Abstract: The present invention provides methods for determining response to neoadjuvant therapy and metastasis-free survival in pancreatic ductal adenocarcinoma based upon the level of microRNA expression and optionally the presence of a protein cancer cell marker in biological samples such as formalin-fixed paraffin-embedded specimens using in situ hybridization and optionally an immunohistochemical assay.
    Type: Grant
    Filed: June 29, 2011
    Date of Patent: November 12, 2013
    Assignee: Trustees of Dartmouth College
    Inventors: Lorenzo F. Sempere, Murray Korc, Meir Preis
  • Methods for Determining Response to Neoadjuvant Therapy and Survival Using MicroRNA-10b
    Publication number: 20120021415
    Abstract: The present invention provides methods for determining response to neoadjuvant therapy and metastasis-free survival in pancreatic ductal adenocarcinoma based upon the level of microRNA expression and optionally the presence of a protein cancer cell marker in biological samples such as formalin-fixed paraffin-embedded specimens using in situ hybridization and optionally an immunohistochemical assay.
    Type: Application
    Filed: June 29, 2011
    Publication date: January 26, 2012
    Applicant: TRUSTEES OF DARTMOUTH COLLEGE
    Inventors: Lorenzo F. Sempere, Murray Korc, Meir Preis
  • Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same
    Patent number: 7767201
    Abstract: This invention relates to a method for producing angiogenesis in a tissue of a patient by administering vascular cells genetically altered to over-express an angiogenic proliferation factor and an angiogenic maturation factor to the affected tissue.
    Type: Grant
    Filed: May 2, 2003
    Date of Patent: August 3, 2010
    Assignee: Multi-Gene Vascular Systems Ltd.
    Inventors: Moshe Y. Flugelman, Zoya Gluzman, Meir Preis, Belly Koren, Tzafra Cohen, Adili Tsaba, Anat Weisz
  • Nucleic acid constructs cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
    Patent number: 7524493
    Abstract: A method of inducing liver regeneration in a damaged liver tissue region of an individual is provided. The method including the step of providing at least two distinct growth factors to the damaged liver tissue region of the individual, at least one of the at least two distinct growth factors being an angiogenic factor.
    Type: Grant
    Filed: February 28, 2002
    Date of Patent: April 28, 2009
    Assignee: M.G.V.S. Ltd.
    Inventors: Moshe Y. Flugelman, Zoya Gluzman, Meir Preis, Belly Koren, Tzafra Cohen, Adili Tsaba, Michael Ott
  • Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same
    Publication number: 20040151707
    Abstract: This invention relates to a method for producing angiogenesis in a tissue of a patient by administering vascular cells genetically altered to over-express an angiogenic proliferation factor and an angiogenic maturation factor to the affected tissue.
    Type: Application
    Filed: May 2, 2003
    Publication date: August 5, 2004
    Inventors: Moshe Y. Flugelman, Zoya Gluzman, Meir Preis, Belly Koren, Tzafra Cohen, Adili Tsaba, Anat Weisz
  • Nucleic acid constructs cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
    Publication number: 20040116343
    Abstract: A method of inducing liver regeneration in a damaged liver tissue region of an individual is provided. The method including the step of providing at least two distinct growth factors to the damaged liver tissue region of the individual, at least one of the at least two distinct growth factors being an angiogenic factor.
    Type: Application
    Filed: September 2, 2003
    Publication date: June 17, 2004
    Inventors: Moshe Y. Flugelman, Zoya Gluzman, Meir Preis, Belly Koren, Tzafra Cohen, Adili Tsaba, Michael Ott